Pergonal Market Report 2026

Pergonal Market Overview

• The Pergonal market growth in the historic period has been driven by increasing infertility prevalence among women, growing awareness of fertility treatment options • Market expansion is supported by increasing demand for assisted reproductive technologies, rising investments in fertility care infrastructure • Growth Driver: Rising Prevalence Of Infertility Driving Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pergonal Market?

Pergonal is a biologic drug that contains a combination of human menopausal gonadotropin (hMG), which includes both luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is primarily used in fertility treatments to stimulate ovulation in women who have difficulty conceiving due to anovulation. It is derived from the urine of postmenopausal women and helps stimulate the ovaries to produce eggs. The main indications in the pergonal market are infertility treatment, hypogonadism, and ovarian stimulation. Infertility refers to the inability of a couple to conceive after trying for at least one year without using contraception. The distribution channels encompass pharmacies and online pharmacies, while the end users include hospitals, fertility clinics, and home care settings.

What Is The Pergonal Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for assisted reproductive technologies, rising investments in fertility care infrastructure, growing focus on personalized hormone dosing, expansion of fertility treatment access in emerging markets, increasing clinical research in reproductive endocrinology. Major trends in the forecast period include increasing adoption of hormonal fertility therapies, rising demand for assisted reproductive treatments, growing use of urine-derived gonadotropins, expansion of specialized fertility clinics, enhanced focus on personalized ovulation induction protocols.

Global Pergonal Market Segmentation

1) By Indication: Infertility Treatment, Hypogonadism, Ovarian Stimulation 2) By Distribution Channel: Pharmacies, Online Pharmacies 3) By End User: Hospitals, Fertility Clinics, Home Care

What Are The Drivers Of The Pergonal Market?

The increasing prevalence of infertility is expected to propel the growth of the pergonal market going forward. Infertility refers to the inability to conceive or maintain a pregnancy or to carry it to term. Infertility is on the rise due to factors such as delayed childbearing, lifestyle choices, environmental toxins, and increasing prevalence of medical conditions such as polycystic ovary syndrome (PCOS) and endometriosis. Pergonal helps patients with infertility by stimulating ovulation through its combination of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), promoting egg production in women with ovulatory dysfunction. For instance, in April 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, approximately 17.5% of the global adult population, or about 1 in 6 individuals, face infertility. Thus, the increasing prevalence of infertility is driving the growth of the pergonal industry. The increasing adoption of IVF procedures is expected to propel the growth of the pergonal market going forward. IVF procedures refer to medical treatments that assist individuals or couples in conceiving by fertilizing an egg with sperm outside the body and implanting the resulting embryo into the uterus. Adoption of IVF procedures is increasing as more people delay parenthood due to career, education, or social reasons, resulting in age-related fertility decline and greater reliance on fertility treatments. Pergonal supports the adoption of IVF procedures by stimulating the ovaries to produce multiple mature eggs, thereby improving the likelihood of successful fertilization and embryo development. For instance, in June 2025, the Human Fertilisation & Embryology Authority, a UK-based independent regulator of fertility treatment, reported that, in 2023, 52,400 patients had over 77,500 in vitro fertilization (IVF) cycles at licensed fertility clinics in the UK. Egg freezing cycles increased from 4,700 in 2022 to 6,900 in 2023, accounting for 7% of all cycles. Therefore, increasing adoption of IVF procedures is driving the growth of the pergonal industry. Growing healthcare expenditure is expected to fuel the growth of the pergonal market going forward. Healthcare expenditure is attributed to factors such as the rising prevalence of chronic diseases, advancements in medical technologies, aging populations, and increasing demand for quality healthcare services. Rising healthcare expenditure supports the growth of pergonal by enabling greater access to advanced fertility treatments and increasing the affordability of assisted reproductive technologies for patients. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Thus, growing healthcare expenditure will drive the pergonal industry.

Key Players In The Global Pergonal Market

Major companies operating in the pergonal market are Merck KGaA

Regional Insights

North America was the largest region in the pergonal market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Pergonal Market?

The pergonal market consists of sales of menotropins, luteinizing hormone, and follicle-stimulating hormones. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pergonal Market Report 2026?

The pergonal market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pergonal industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.